Altera: Analysts' Upgrades, Downgrades

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Autodesk (ADSK Quote) downgraded at Morgan Stanley from Equal-weight to Underweight. $22 price target. Stock is pricing in too much near-term growth.

AIG (AIG Quote) downgraded at Credit Suisse to Underperform from Neutral. 2009 and 2010 EPS estimates set at -$13.98 and $5.70, respectively. Price target lowered to $15 from $30.

Altera (ALTR Quote) upgraded at Morgan Stanley from Underweight to Overweight. $23 price target. Stock is already pricing in risks, like the potential for slower orders from China.

Amphenol (APH Quote) upgraded at Weisel from Market-weight to Overweight. $42 price target. Stock has underperformed its peers in recent months, but remains a best-in-class operator.

Array BioPharma (ARRY Quote) downgraded at UBS to Neutral from Buy. 2010 and 2011 EPS estimates set at $2.02 and $1.78, respectively. Price target lowered to $3.25 from $5.50.

Broadcom (BRCM Quote) upgraded at Roth to Buy. $34 price target. Company should benefit from multiple new product cycles and a recovery in enterprise spending.

Cracker Barrel (CRBL Quote) upgraded at Merrill/BofA to Buy from Underperform as CBRL has outperformed the industry from a restaurant sales perspective. 2009 and 2010 EPS estimates set at $2.80 and $3.05, respectively. Price target boosted from $24 to $37.

CareFusion (CFN Quote) initiated at Barclays with an Equal Weight rating and $20 price target. Analysts mentioned CFN is big player in growing niche med technologies. 2010 and 2011 EPS estimates set at $1.14 and $1.36, respectively.

Chattem (CHTT Quote) initiated at Merrill/BofA. Initiated with a Buy rating and $70 price target. Introduces 2009 EPS estimates of $4.55.